Table 4.

General data, Lp-PLA₂ and IMA of neurological impairment and normal neurological function groups.

	Neurological impairment group (n = 25)	Normal neurological function group (n = 95)	t/$\chi$2	p
Gender (male/female)	12/13	56/39	0.967	0.326
Age (year)	56.56 $\pm$ 5.23	56.71 $\pm$ 5.34	0.126	0.900
BMI (kg/m2)	23.14 $\pm$ 2.51	23.16 $\pm$ 2.56	0.034	0.972
Hypertension (Yes/No)	16/9	25/70	12.495	0.001
Coronary heart disease (Yes/No)	18/7	23/72	28.044	0.001
Family history of stroke (Yes/No)	10/15	17/78	5.546	0.019
Smoking and drinking history (Yes/No)	19/6	28/67	17.981	0.001
FBG (mmol/L)	8.92 $\pm$ 1.02	6.43 $\pm$ 0.52	16.950	0.001
TC (mmol/L)	4.72 $\pm$ 0.36	4.77 $\pm$ 0.45	0.514	0.609
Duration from onset to admission (h)	6.12 $\pm$ 0.93	4.00 $\pm$ 0.43	16.590	0.001
NIHSS at admission (point)	12.55 $\pm$ 1.34	8.43 $\pm$ 0.58	23.030	0.001
Lp-PLA2 (µg/L)	253.91 $\pm$ 29.03	65.93 $\pm$ 5.12	60.310	0.001
IMA (U/mL)	119.28 $\pm$ 15.43	76.91 $\pm$ 6.41	20.920	0.001